A Phase II Clinical Trial of Flutamide in the Treatment of Advanced Breast Cancer

1988 ◽  
Vol 74 (1) ◽  
pp. 53-56 ◽  
Author(s):  
Tiping Zhao ◽  
Guifen He
Keyword(s):  
Breast Cancer ◽  
Clinical Trial ◽  
Advanced Breast Cancer ◽  
Cancer Patients ◽  
Phase Ii ◽  
Transient Response ◽  
Postmenopausal Breast Cancer ◽  
Phase Ii Clinical Trial ◽  
Advanced Breast ◽  
Breast Cancer Patients

An antiandrogenic agent flutamide was used in the treatment of one male and 14 female postmenopausal breast cancer patients. Only a mild and transient response was seen in 2 female patients. Therefore, flutamide cannot be used solely in the treatment of female postmenopausal breast cancer.

A phase II clinical trial to analyze olaparib response in patients with BRCA1 and/or BRCA2 promoter methylation with advanced breast cancer (GEICAM/2015-06 COMETA-Breast study).

2018 ◽  
Vol 36 (15_suppl) ◽  
pp. TPS1114-TPS1114
Author(s):  
Juan De La Haba ◽  
Angel Guerrero-Zotano ◽  
Jose Alejandro Perez-Fidalgo ◽  
Santiago Gonzalez Santiago ◽  
Montserrat Muñoz ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Clinical Trial ◽  
Advanced Breast Cancer ◽  
Phase Ii ◽  
Promoter Methylation ◽  
Phase Ii Clinical Trial ◽  
Advanced Breast

A phase II trial with D-Trp-6 (decapeptyl) in premenopausal RH+, hormonal untreated advanced breast cancer patients

1993 ◽  
Vol 29 ◽  
pp. S86
Author(s):  
E. Garcia-Giralt ◽  
P. Beuzeboc ◽  
T. Dorval ◽  
M. Jouve ◽  
A. Livartowski ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Advanced Breast Cancer ◽  
Cancer Patients ◽  
Phase Ii ◽  
Phase Ii Trial ◽  
Advanced Breast ◽  
Breast Cancer Patients
Sign in / Sign up

Export Citation Format

Share Document